← TransMedics Group, Inc.
| Annual Trend | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Accounts receivable | $3.4m | $6.6m | $6.9m | $5.9m | $27.6m | $63.6m | $97.7m | $84.3m | |
| Inventory | $9.3m | $11.2m | $11.9m | $14.9m | $20.6m | $44.2m | $46.6m | $48.9m | |
| Prepaid expenses and other current assets | $1.8m | $1.5m | $2.3m | $5.5m | $2.9m | $8.0m | $16.3m | $16.3m | |
| Total current assets | $34.8m | $100.0m | $146.8m | $118.7m | $252.3m | $510.7m | $497.2m | $637.8m | |
| Property, plant and equipment, net | $3.5m | $4.8m | $4.8m | $9.8m | $19.2m | $173.9m | $286.0m | $327.7m | |
| Goodwill | — | — | — | — | — | $12.0m | $11.5m | $11.5m | |
| Acquired intangible assets, net | — | — | — | — | — | $2.4m | $2.2m | $1.9m | |
| Operating lease right-of-use assets | — | — | — | $5.8m | $5.1m | $6.5m | $6.5m | $5.2m | |
| Cash | — | — | — | — | $201.2m | $394.8m | $336.6m | $488.4m | |
| Deferred tax assets | — | — | — | — | — | — | — | $83.5m | |
| Restricted cash | $500k | $500k | $500k | $500k | $500k | $500k | $500k | $500k | |
| Other non-current assets | $6k | $6k | $6k | — | — | $62k | $208k | $239k | |
| Accrued expenses and other current liabilities | $7.2m | $8.3m | $10.3m | $16.3m | $18.6m | $38.2m | $45.2m | $62.7m | |
| Deferred revenue | $306k | $166k | $263k | $250k | $241k | $2.0m | $1.7m | $2.9m | |
| Operating lease liabilities | — | — | — | — | $1.4m | $2.0m | $2.7m | $3.3m | |
| Convertible senior notes, net | — | — | — | — | — | $447.1m | $449.9m | $452.8m | |
| Operating lease liabilities, net of current portion | — | — | — | $8.6m | $7.4m | $7.7m | $6.2m | $3.6m | |
| Total stockholders’ equity | ($192.2m) | $54.6m | $103.9m | $67.9m | $187.4m | $137.2m | $228.6m | $473.1m | |
| Total assets | $42.2m | $105.3m | $152.0m | $134.9m | $277.1m | $706.0m | $804.1m | $1.1b | |
| Total liabilities and stockholders’ equity | $42.2m | $105.3m | $152.0m | $134.9m | $277.1m | $706.0m | $804.1m | $1.1b | |
| Accounts payable | $4.7m | $7.2m | $1.2m | $6.7m | $3.3m | $12.7m | $10.3m | $10.3m | |
| Long-Term Debt, Current Maturities | — | — | — | — | — | — | — | $10.0m | |
| Total current liabilities | $12.6m | $16.1m | $11.9m | $23.2m | $23.7m | $54.9m | $59.9m | $89.3m | |
| Long-term debt, net | $33.7m | $34.1m | $34.7m | $35.2m | $58.7m | $59.1m | $59.4m | $49.6m | |
| Total liabilities | $47.9m | $50.6m | $48.1m | $67.0m | $89.8m | $568.8m | $575.5m | $595.3m | |
| Common stock, no par value; 150,000,000 shares authorized; 34,267,802 shares and 33,617,972 shares issued and outstanding as of December 31, 2025 and 2024, respectively | 1k | 424.1m | 502.2m | 510.5m | 666.3m | 641.1m | 697.2m | 750.9m | |
| Accumulated other comprehensive loss | ($101k) | ($2k) | ($95k) | ($188k) | ($225k) | ($199k) | ($364k) | $124k | |
| Accumulated deficit | ($335.9m) | ($369.5m) | ($398.2m) | ($442.4m) | ($478.7m) | ($503.7m) | ($468.2m) | ($277.9m) |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.